Is ecstasy a drug of dependence?

Drug and Alcohol Dependence

Volumn 107, Issue 1, 2010, Pages 1-10

  Degenhardt, Louisa ^a   Bruno, Raimondo ^b   Topp, Libby ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c Justice Health Centre for Health Research in Criminal Justice   (Australia)

Author keywords

Amphetamines; Dependence; Ecstasy; MDMA; Nosology

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; COCAINE; METHAMPHETAMINE;

BEHAVIORAL RESEARCH; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HELP SEEKING BEHAVIOR; HUMAN; MEDICAL RESEARCH; NEUROBIOLOGY; NOMENCLATURE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; THEORETICAL MODEL; WITHDRAWAL SYNDROME;

ANIMALS; BEHAVIOR, ANIMAL; HALLUCINOGENS; HUMANS; MODELS, NEUROLOGICAL; MODELS, PSYCHOLOGICAL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POPULATION SURVEILLANCE; SUBSTANCE-RELATED DISORDERS;

ANIMALIA;

EID: 74749100137     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.09.009     Document Type: Review

References (105)

1. Abdallah A., Scheier L., Inciardi J., Copeland J., and Cottler L. A psycho-economic model of ecstasy consumption and related consequences: a multi-site study with community samples. Substance Use and Misuse 42 (2007) 1651-1684
2. Aberg M., Wade D., Wall E., and Izenwasser S. Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats. Neurotoxicology and Teratology 29 (2007) 37-46
3. Altman J., Everitt B., Glautier S., Markou A., Nutt D., Oretti R., Phillips G., and Robbins T. The biological, social and clinical bases of drug addiction: commentary and debate. Psychopharmacology 125 (1996) 285-345
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fourth edition-Technical Revision (2000), American Psychiatric Association, Washington, DC
5. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: First Results (2005), Australian Institute of Health and Welfare, Canberra
6. Australian Institute of Health and Welfare. Alcohol and Other Drug Treatment Services in Australia 2004-2005: Report on the National Minimum Data Set. Drug Treatment Series Number 5. AIHW cat. no. HSE 43 (2006), AIHW, Canberra
7. Ball K.T., Walsh K.M., and Rebec G.V. Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues. Pharmacology and Biochemical Behaviour 87 (2007) 420-425
8. Bankson M.G., and Yamamoto B.K. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release. Journal of Neurochemistry 91 (2004) 852-859
9. Beardsley P.M., Balster R.L., and Harris L.S. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys. Drug and Alcohol Dependence 18 (1986) 149-157
10. Bruno, R., Matthews, A.J., Topp, L., Degenhardt, L., Gomez, R., Dunn, M., 2009. Can the Severity of Dependence Scale be usefully applied to 'ecstasy'? Neuropsychobiology, in press.
11. Callaway C., and Geyer M. Stimulant effects of 3,4-methylenedioxymethamphetamine in the nucleus accumbens of rat. European Journal of Psychopharmacology 214 (1992) 45-51
12. Clemens K.J., McGregor I.S., Hunt G.E., and Cornish J.L. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug and Alcohol Review 26 (2007) 9-15
13. Collusi-Mas S., and Schenk J. Acute and sensitized response to 3,4-methylenedioxymethamphetamine in rats: different behavioral profiles reflected in different patterns of Fos expression. European Journal of Neuroscience 28 (2008) 1895-1910
14. Cottler L.B., Womack S.B., Compton W.M., and Ben-Abdallah A. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Human Psychopharmacology: Clinical and Experimental 16 (2001) 599-606
15. Daniela E., Gittings D., and Schenk S. Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration. Behaviour Neuroscience 120 (2006) 1144-1150
16. Daza-Losada M., Ribeiro Do Couto B., Manzanedo C., Aguilar M.A., Rodriguez-Arias M., and Minarro J. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 32 (2007) 1750-1759
17. Daza-Losada M., Rodriguez-Arias M., Aguliar M., and Minarro J. Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induced CPP. Progress in Neuropsychopharmacology and Biological Psychiatry 32 (2008) 701-709
18. de las Cuevas C., Sanz E.J., de la Fuente J.A., Padilla J., and Berenguer J.C. The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95 (2000) 245-250
19. Diller A., Rocha A., Cardon A., Valles R., Wellman P., and Nation J. The effects of concurrent administration of +/-3,4-methyeledioxymethamphetamine and cocaine on conditioned placed preference in the adult male rat. Pharmacology, Biochemistry and Behavior 88 (2007) 165-170
20. Drummond D.C., Tiffany S., Glautier S., and Remington B. Cue exposure in understanding and treating addictive behaviours. In: Drummond D.C., Tiffany S., Glautier S., and Remington B. (Eds). Addictive Behaviour: Cue Exposure Theory and Practice (1995), John Wiley & Sons Ltd., Chichester 1-17
21. Dunn M., Degenhardt L., Campbell G., George J., Johnston J., Kinner S., Matthews A., Newman A., and White N. Australian Trends in Ecstasy and Related Drug Markets 2006:Findings from the Ecstasy and Related Drugs Reporting System (EDRS). NDARC Monograph 61 (2007), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
22. Edwards G., and Gross M. Alcohol dependence: provisional description of a clinical syndrome. British Medical Journal 1 (1976) 1058-1061
23. Edwards G., Gross M., Keller M., Moser J., and Room R. Alcohol-related Disabilities (1977), WHO Offset Publication No 32. World Health Organization, Geneva
24. Everitt B., and Robbins T. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Reviews Neuroscience 8 (2005) 1481-1489
25. Fantegrossi W.E. Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?. Psychopharmacology 189 (2007) 471-482
26. Fantegrossi W.E., Woolverton W.L., Kilbourn M., Sherman P., Yuan J., Hatzidimitriou G., Ricaurte G., Woods J.H., and Winger G. Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 29 (2004) 1270-1281
27. Fletcher P., Robinson S., and Slippoy D. Pre-exposure to 3,4-methyeledioxymethamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats. Neuropsychopharmacology 25 (2001) 195-203
28. Gossop M., Darke S., Griffiths P., Hando J., Powis B., Hall W., and Strang J. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 90 (1995) 607-614
29. Gossop M., Griffiths P., Powis B., and Strang J. Severity of dependence and route of administration of heroin, cocaine and amphetamines. British Journal of Addiction 87 (1992) 1527-1536
30. Greeley J., and Westbrook F. Associative learning, drug use and addictive behaviour. In: Heather N., Miller W., and Greeley J. (Eds). Self-control and the Addictive Behaviours (1991), Maxwell Macmillan Publishing, Australia, Sydney 127-152
31. Hall W., Lynskey M., and Degenhardt L. Heroin Use in Australia: Its Impact upon Public Health and Public Order (1999), National Drug and Alcohol Research Centre, UNSW, Sydney
32. Hando J., Topp L., and Hall W. Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. Drug and Alcohol Dependence 46 (1997) 105-113
33. Hanson K.L., and Luciana M. Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. Psychological Medicine 34 (2004) 229-246
34. Hasin D., Hatzenbuehler M., Keyes K., and Ogburn E. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10). Addiction 101 (2006) 51-75
35. Heather N., and Greeley J. Cue exposure in the treatment of drug dependence: the potential of a new method for preventing relapse. Drug and Alcohol Review 9 (1990) 155-168
36. Hopper J.W., Su Z., Looby A.R., Ryan E.T., Penetar D.M., Palmer C.M., and Lukas S.E. Incidence and patterns of polydrug use and craving for ecstasy in regular ecstasy users: an ecological momentary assessment study. Drug and Alcohol Dependence 85 (2006) 221-235
37. Institute of Medicine. Pathways of Addiction (1996), National Academy Press, Washington
38. Jansen K.L. Ecstasy (MDMA) dependence. Drug and Alcohol Dependence 53 (1999) 121-124
39. Kalivas P., Duffy P., and White S. MDMA elicits behavioural and neurochemical sensitization in rats. Neuropsychopharmacology 18 (1998) 469-479
40. Kaye S., and Darke S. Determining a diagnostic cut-off on the Severity of Dependence Scale (SDS) for cocaine dependence. Addiction 97 (2002) 727-731
41. Kendell R.E. Clinical validity. Psychological Medicine 19 (1989) 45-55
42. Kendell R.E. Clinical validity. In: Robins L.N., and Barrett J.E. (Eds). The Validity of Psychiatric Diagnosis (1989), Raven Press, New York 305-321
43. Kenny J. Brain reward systems and compulsive drug use. Trends in Pharmacological Science 28 (2007) 135-141
44. Kidorf M., Brooner R.K., King V.L., Stoller K.B., and Wertz J. Predictive validity of cocaine, sedative, and alcohol dependence diagnoses. Journal of Consulting and Clinical Psychology 66 (1998) 168-173
45. Koob G. The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101 (2006) 23-30
46. Koob G., Caine S., Parsons L., Markou A., and Weiss F. Opponent process model and psychostimulant addiction. Pharmacology, Biochemistry and Behavior 57 (1997) 513-521
47. Koob G., and LeMoal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
48. Koob G.F., and LeMoal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
49. Koob G.F., and LeMoal M. Neurobiology of Addiction (2005), Academic Press, New York
50. Lamb R.J., and Griffiths R.R. Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon. Psychopharmacology 91 (1987) 268-272
51. Leshner A. Addiction is a brain disease-and it matters. Science 278 (1997) 45-47
52. Leung K.S., and Cottler L.B. Ecstasy and other club drugs: a review of recent epidemiologic studies. Current Opinion in Psychiatry 21 (2008) 234-241
53. Lile J.A., Ross J.T., and Nader M.A. A comparison of the reinforcing efficacy of 3,4-methyeledioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug and Alcohol Dependence 78 (2005) 135-140
54. Maxwell J.C., and Spence R.T. Profiles of club drug users in treatment. Substance Use and Misuse 40 (2005) 1409-1426
55. Morgenstern J., Langenbucher J., and Labouvie E.W. The generalisability of the dependence syndrome across substances: an examination of some properties of the proposed DSM-IV dependence criteria. Addiction 89 (1994) 1105-1115
56. Muller C.P., Carey R.J., Huston J.P., and De Souza Silva M.A. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors. Progress in Neurobiology 81 (2007) 133-178
57. Nelson C.B., Rehm J., Üstün T.B., Grant B., and Chatterji S. Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: results from the WHO reliability and validity study. Addiction 94 (1999) 843-855
58. Nestler E.J. Is there a common molecular pathway for addiction?. Nature Neuroscience 8 (2005) 1445-1449
59. Nutt D. The neurochemistry of addiction. Human Psychopharmacology 12 (1997) s53-s58
60. O'Brien C., Volkow N., and Li T. What's in a word? Addiction versus dependence in DSM-V. American Journal of Psychiatry 163 (2006) 764-765
61. Parsons J.T., Grov C., and Kelly B.C. Club drug use and dependence among young adults recruited through time-space sampling. Public Health Report 124 (2009) 246-254
62. Peroutka S.J. Recreational use of MDMA. In: Peroutka S.J. (Ed). Ecstasy: The Clinical, Pharmacological and Neurotoxicological Effects of the Drug MDMA (1990), Kluwer, MA 53-63
63. Quinn C., Dunn M., and Degenhardt L. The Illicit Tablet Market in Victoria. Ecstasy and Related Drug Trends Bulletin, December (2007), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
64. Ramos M., Goni-Allo B., and Aguirre N. Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioural sensitisation in rats. Psychopharmacology 177 (2004) 111-110
65. Ratzenboeck E., Saria A., Kriechbaum N., and Zernig G. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Pharmacology 62 (2001) 138-144
66. Robins E., and Guze S. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. American Journal of Psychiatry 126 (1970) 983-987
67. Robins L. Using survey results to improve the validity of the standard psychiatric nomenclature. Archives of General Psychiatry 61 (2004) 1188-1194
68. Robinson T., and Berridge K. Incentive-sensitization and addiction. Addiction 96 (2001) 103-114
69. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Research and Brain Research Reviews 18 (1993) 247-291
70. Robledo P., Balerio G., Berrendero F., and Maldonado R. Study of the behavioural responses related to the potential addictive properties of MDMA in mice. Naunyn-Schmiedebergs Archives of Pharmacology 369 (2004) 338-349
71. Robledo P., Mendizabal V., Ortuno J., de la Torre R., Kieffer B.L., and Maldonado R. The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors. European Journal of Neuroscience 20 (2004) 853-858
72. Scheier L.M., Ben Abdallah A., Inciardi J.A., Copeland J., and Cottler L.B. Tri-city study of Ecstasy use problems: a latent class analysis. Drug and Alcohol Dependence 98 (2008) 249-263
73. Schenk S., Gittings D., Johnstone M., and Daniela E. Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169 (2003) 21-27
74. Schenk S., Hely L., Gittings D., Lake B., and Daniela E. Effects of priming injections of MDMA and cocaine on reinstatement of MDMA- and cocaine-seeking in rats. Drug and Alcohol Dependence 96 (2008) 249-255
75. Schenk S., Hely L., Lake B., Daniela E., Gittings D., and Mash D. MDMA self-administration in rats: acquisition, progressive ration responding and serotonin transporter binding. European Journal of Neuroscience 26 (2007) 3229-3236
76. Schuckit M.A., and Saunders J.B. The empirical basis of substance use disorders diagnosis: research recommendations for the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V). Addiction 101 (2006) 170-173
77. Schulteis G., Ahmed S., Morse A., Koob G., and Everitt B. Conditioning and opiate withdrawal: the amygdala links neutral stimuli with the agony of overcoming drug addiction. Nature 405 (2000) 1013-1014
78. Shin R., Quin M., Liu Z., and Ikemoto S. Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tuberclele. Psychopharmacology 198 (2008) 261-270
79. Stewart J., de Wit H., and Eikelboom R. Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychological Review 91 (1984) 251-268
80. Stone A.L., O'Brien M.S., De La Torre A., and Anthony J.C. Who is becoming hallucinogen dependent soon after hallucinogen use starts?. Drug and Alcohol Dependence 87 (2007) 153-163
81. Stone A.L., Storr C.L., and Anthony J.C. Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence. International Journal of Methods in Psychiatric Research 15 (2006) 116-130
82. Thomasius R., Petersen K.U., Zapletalova P., Wartberg L., Zeichner D., and Schmoldt A. Mental disorders in current and former heavy ecstasy (MDMA) users. Addiction 100 (2005) 1310-1319
83. Topp, L., Hall, W., Hando, J., 1997. Is there a dependence syndrome for ecstasy? NDARC Technical Report No. 51. National Drug and Alcohol Research Centre, University of NSW, Sydney. http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR_26/$file/TR.051.pdf.
84. Topp L., Hando J., Dillon P., and Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug and Alcohol Dependence 55 (1999) 105-115
85. Topp L., and Mattick R. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 92 (1997) 839-845
86. Topp L., and Mattick R. Validation of the amphetamine dependence syndrome and the SamDQ. Addiction 92 (1997) 157-167
87. Tossman P. The use of cannabis, ecstasy and amphetamines: is there a specific need for treatment?. Sucht 50 (2004) 164-171
88. Trigo J.E., Panayi F., Soria G., Maldonado R., and Robeldo P. A reliable model of intravenous MDMA self-administration in naïve mice. Psychopharmacology 184 (2006) 212-220
89. United Nations Office on Drugs and Crime. 2008 Global ATS Assessment: Amphetamines and Ecstasy (2008), United Nations, Vienna
90. United Nations Office on Drugs and Crime. World Drug Report 2008 (2008), United Nations, Vienna
91. United Nations Office on Drugs and Crime. World Drug Report 2008 (2009), United Nations, Vienna
92. Volkow N., and Li T.-K. Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews in Neuroscience 5 (2004) 963-970
93. von Sydow K., Lieb R., Pfister H., Hofler M., and Wittchen H.-U. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults-a transient phenomenon? Results from a longitudinal community study. Drug and Alcohol Dependence 66 (2002) 147-159
94. Wang Z., and Woolverton W.L. Estimating the relative reinforcing strengths of (±)-3,4-methyeledioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine. Psychopharmacology 189 (2007) 483-488
95. West R. The psychological basis of addiction. International Review of Psychiatry 1 (1989) 71-80
96. West R. Theory of Addiction (2006), Wiley-Blackwell, London
97. White B., Day C., Degenhardt L., Kinner S., Fry C., Bruno R., and Johnston J. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. Drug and Alcohol Dependence 83 (2006) 210-217
98. White B., Degenhardt L., Breen C., Bruno R., Newman J., Proudfoot P., White B., Degenhardt L., Breen C., Bruno R., Newman J., and Proudfoot P. Risk and benefit perceptions of party drug use. Addiction Behaviour 31 (2006) 137-142
99. Winstock A.R., Griffiths P., and Stewart D. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and Alcohol Dependence 64 (2001) 9-17
100. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders-Diagnostic Criteria for Research (1993), World Health Organization, Geneva
101. World Health Organization. Composite International Diagnostic Interview (CIDI) Core Version 2.1, 12 month version (1997), World Health Organization, Geneva
102. Wu L.T., Ringwalt C.L., Mannelli P., and Patkar A.A. Hallucinogen use disorders among adult users of MDMA and other hallucinogens. American Journal of Addiction 17 (2008) 354-363
103. Yacoubian Jr. G.S., Peters R.J., Palacios W.R., and Link T.C. Identifying the perceived and diagnosed prevalence of ecstasy dependence among club rave attendees. Journal of Ethnicity in Substance Abuse 3 (2004) 33-45
104. Yen C.-F., and Hsu S.-Y. Symptoms of ecstasy dependence and correlation with psychopathology in Taiwanese adolescents. Journal of Nervous and Mental Disease 195 (2007) 866-869
105. Zinberg N.E. Drug, Set and Setting: The Basis for Controlled Intoxicant Use (1984), Yale University Press, London